Quest Adds New Blood Biomarker to Alzheimer’s Testing Portfolio
Quest Diagnostics expanded its AD-Detect portfolio of Alzheimer’s tests by adding a blood biomarker test for early disease diagnosis.
Read MorePosted by Andy Lundin | Apr 22, 2024 | Dementias & Alzheimer’s |
Quest Diagnostics expanded its AD-Detect portfolio of Alzheimer’s tests by adding a blood biomarker test for early disease diagnosis.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Cancer |
Unilabs will use the SOPHiA DDM Platform to test for Homologous Recombination Deficiency in solid tumors, particularly in ovarian cancer.
Read MorePosted by Andy Lundin | Apr 15, 2024 | Womens Health |
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MorePosted by Chris Wolski | Apr 11, 2024 | Lab Management |
XiFin has published the reimbursement rates for key pathology and molecular tests, giving key data for benchmarking.
Read MorePosted by Andy Lundin | Apr 9, 2024 | Compliance |
ADLM released the results of a survey the organization conducted to determine how the FDA’s proposed LDT rule would impact patient care.
Read More